Drawing for MYOVANT

USPTO serial 88254852

MYOVANT

Reviewed by CopyMark Law Group

Reg. 5987695Status 710
Filing date
Status date
Registration date
Feb 18, 2020
Examiner
MACFARLANE, JAMES W
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MYOVANT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joyce M. Ferraro

Joyce M. Ferraro FROSS ZELNICK LERHMAN & ZISSU, P.C.151 WEST 42ND STREET, 17TH FLOORNEW YORK, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Scientific and technological services, namely, medical research, scientific research and analysis, and technological consulting in the fields of pharmaceuticals, biomedicine, clinical trials for others and post-market trials for others; pharmaceutical, biomedical and biological therapeutic research services; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials for others and post-market trials for others; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trialsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 28, 2026C8..CANCELLED SEC. 8 (6-YR)—
Feb 18, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 13, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 26, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 26, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 26, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 26, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 26, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 18, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 3, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 3, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 13, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 25, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 25, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Oct 25, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 25, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 25, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 10, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 10, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 7, 2019ALIEASSIGNED TO LIE—
Sep 29, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 28, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 28, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 28, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2019DOCKASSIGNED TO EXAMINER—
Jan 30, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 12, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance